89 related articles for article (PubMed ID: 21070758)
1. Relationship between metabolic disorders and relative risk values of brain infarction estimated by protein-conjugated acrolein, IL-6 and CRP together with age.
Yoshida M; Mizoi M; Saiki R; Kobayashi E; Saeki N; Wakui K; Kusaka T; Takizawa H; Kashiwado K; Suzuki N; Fukuda K; Nakamura T; Watanabe S; Tada K; Tomitori H; Kashiwagi K; Igarashi K
Clin Chim Acta; 2011 Jan; 412(3-4):339-42. PubMed ID: 21070758
[TBL] [Abstract][Full Text] [Related]
2. Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP.
Yoshida M; Higashi K; Kobayashi E; Saeki N; Wakui K; Kusaka T; Takizawa H; Kashiwado K; Suzuki N; Fukuda K; Nakamura T; Watanabe S; Tada K; Machi Y; Mizoi M; Toida T; Kanzaki T; Tomitori H; Kashiwagi K; Igarashi K
Atherosclerosis; 2010 Aug; 211(2):475-9. PubMed ID: 20417516
[TBL] [Abstract][Full Text] [Related]
3. Acrolein, IL-6 and CRP as markers of silent brain infarction.
Yoshida M; Tomitori H; Machi Y; Katagiri D; Ueda S; Horiguchi K; Kobayashi E; Saeki N; Nishimura K; Ishii I; Kashiwagi K; Igarashi K
Atherosclerosis; 2009 Apr; 203(2):557-62. PubMed ID: 18757054
[TBL] [Abstract][Full Text] [Related]
4. Protein-conjugated acrolein as a biochemical marker of brain infarction.
Igarashi K; Kashiwagi K
Mol Nutr Food Res; 2011 Sep; 55(9):1332-41. PubMed ID: 21732531
[TBL] [Abstract][Full Text] [Related]
5. Acrolein stimulates the synthesis of IL-6 and C-reactive protein (CRP) in thrombosis model mice and cultured cells.
Saiki R; Hayashi D; Ikuo Y; Nishimura K; Ishii I; Kobayashi K; Chiba K; Toida T; Kashiwagi K; Igarashi K
J Neurochem; 2013 Dec; 127(5):652-9. PubMed ID: 23763486
[TBL] [Abstract][Full Text] [Related]
6. Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during stroke.
Yoshida M; Kato N; Uemura T; Mizoi M; Nakamura M; Saiki R; Hatano K; Sato K; Kakizaki S; Nakamura A; Ishii T; Terao T; Murayama Y; Kashiwagi K; Igarashi K
eNeurologicalSci; 2017 Jun; 7():18-24. PubMed ID: 29260020
[TBL] [Abstract][Full Text] [Related]
7. Correlation between brain damage, associated biomarkers, and medication in psychiatric inpatients: A cross-sectional study.
Yoshida M; Kanzaki T; Mizoi M; Nakamura M; Uemura T; Mimori S; Uju Y; Sekine K; Ishii Y; Yoshimi T; Yasui R; Yasukawa A; Sato M; Okamoto S; Hisaoka T; Miura M; Kusanishi S; Murakami K; Nakano C; Mizuta Y; Mishima S; Hayakawa T; Tsukada K; Kashiwagi K; Igarashi K
Clin Chim Acta; 2017 Jan; 464():50-56. PubMed ID: 27816667
[TBL] [Abstract][Full Text] [Related]
8. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction.
Hoshi T; Kitagawa K; Yamagami H; Furukado S; Hougaku H; Hori M
Stroke; 2005 Apr; 36(4):768-72. PubMed ID: 15746456
[TBL] [Abstract][Full Text] [Related]
9. Use of polyamine metabolites as markers for stroke and renal failure.
Igarashi K; Kashiwagi K
Methods Mol Biol; 2011; 720():395-408. PubMed ID: 21318888
[TBL] [Abstract][Full Text] [Related]
10. Relative risk values of age, acrolein, IL-6 and CRP as markers of periventricular hyperintensities: a cross-sectional study.
Abe A; Nishiyama Y; Harada-Abe M; Okubo S; Ueda M; Mishina M; Katayama Y
BMJ Open; 2014; 4(8):e005598. PubMed ID: 25232562
[TBL] [Abstract][Full Text] [Related]
11. Association of soluble adhesion molecule and C-reactive protein levels with silent brain infarction in patients with and without type 2 diabetes.
Umemura T; Kawamura T; Sakakibara T; Kanai A; Sano T; Hotta N; Sobue G
Curr Neurovasc Res; 2008 May; 5(2):106-11. PubMed ID: 18473826
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people.
Kwon HM; Kim BJ; Lee SH; Choi SH; Oh BH; Yoon BW
Stroke; 2006 Feb; 37(2):466-70. PubMed ID: 16373631
[TBL] [Abstract][Full Text] [Related]
13. Toxic acrolein production due to Ca(2+) influx by the NMDA receptor during stroke.
Nakamura M; Uemura T; Saiki R; Sakamoto A; Park H; Nishimura K; Terui Y; Toida T; Kashiwagi K; Igarashi K
Atherosclerosis; 2016 Jan; 244():131-7. PubMed ID: 26630182
[TBL] [Abstract][Full Text] [Related]
14. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study.
Satizabal CL; Zhu YC; Mazoyer B; Dufouil C; Tzourio C
Neurology; 2012 Mar; 78(10):720-7. PubMed ID: 22357713
[TBL] [Abstract][Full Text] [Related]
15. The association of metabolic risk factors and silent brain infarctions in healthy Taiwanese.
Chen CH; Lin WC; Chang WN; Tsai NW; Wang HC; Huang CR; Lin YJ; Cheng BC; Su YJ; Kung CT; Lui CC; Lee LH; Lu CH
Acta Neurol Taiwan; 2012 Mar; 21(1):18-24. PubMed ID: 22879085
[TBL] [Abstract][Full Text] [Related]
16. Carotid atherosclerosis, silent ischemic brain damage and brain atrophy: A systematic review and meta-analysis.
Moroni F; Ammirati E; Magnoni M; D'Ascenzo F; Anselmino M; Anzalone N; Rocca MA; Falini A; Filippi M; Camici PG
Int J Cardiol; 2016 Nov; 223():681-687. PubMed ID: 27568989
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
Chapman CM; McQuillan BM; Beilby JP; Thompson PL; Hung J
Atherosclerosis; 2006 Dec; 189(2):414-9. PubMed ID: 16438977
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the risk profile and male predominance in silent brain infarction in community-dwelling elderly subjects: the Sefuri brain MRI study.
Takashima Y; Miwa Y; Mori T; Hashimoto M; Uchino A; Yuzuriha T; Sasaguri T; Yao H
Hypertens Res; 2010 Jul; 33(7):748-52. PubMed ID: 20431593
[TBL] [Abstract][Full Text] [Related]
19. Silent brain infarction and rapid decline of kidney function in patients with CKD: a prospective cohort study.
Kobayashi M; Hirawa N; Morita S; Yatsu K; Kobayashi Y; Yamamoto Y; Saka S; Toya Y; Yasuda G; Umemura S
Am J Kidney Dis; 2010 Sep; 56(3):468-76. PubMed ID: 20537454
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and risk factor analysis of silent brain infarction in patients with first-ever ischemic stroke.
Oh SH; Kim NK; Kim SH; Kim JK; Kim HS; Kim WC; Kim OJ
J Neurol Sci; 2010 Jun; 293(1-2):97-101. PubMed ID: 20356606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
